Karoline Kallis

TU Dortmund, Emil Figge Str. 68
Dortmund, NW 44227, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications

Detection and Localization of Unfavorable-histology Prostate Cancer Using MRI and Whole-mount Histopathology.

Detection and Localization of Unfavorable-histology Prostate Cancer Using MRI and Whole-mount Histopathology.

Journal: European urology oncology
Published: March 03, 2026

Systematic effects of patient factors and scanner/protocol factors on a Restriction Spectrum Imaging (RSI) quantitative MRI biomarker for prostate cancer.

Systematic effects of patient factors and scanner/protocol factors on a Restriction Spectrum Imaging (RSI) quantitative MRI biomarker for prostate cancer.

Journal: Cancer imaging : the official publication of the International Cancer Imaging Society
Published: December 31, 2025

Rapid AI Auto-Planning Rivals Manual Expert Planning for Cervical Brachytherapy.

Rapid AI Auto-Planning Rivals Manual Expert Planning for Cervical Brachytherapy.

Journal: Practical radiation oncology
Published: October 24, 2025

Integration of single-click, AI-based brachytherapy auto-planning for cervical cancer within a treatment planning system.

Integration of single-click, AI-based brachytherapy auto-planning for cervical cancer within a treatment planning system.

Journal: Brachytherapy
Published: July 15, 2025

Reply by Authors.

Reply by Authors.

Journal: The Journal of urology
Published: June 24, 2025

Restriction Spectrum Imaging as a Quantitative Biomarker for Prostate Cancer With Reliable Positive Predictive Value.

Restriction Spectrum Imaging as a Quantitative Biomarker for Prostate Cancer With Reliable Positive Predictive Value.

Journal: The Journal of urology
Published: May 16, 2025

Peripheral Artery Disease in US Primary Care Practices: A Retrospective EHR-Based Analysis from 2018 to 2022.

Peripheral Artery Disease in US Primary Care Practices: A Retrospective EHR-Based Analysis from 2018 to 2022.

Journal: Journal of general internal medicine
Published: April 25, 2025

Utility of quantitative measurement of T2 using restriction spectrum imaging for detection of clinically significant prostate cancer.

Utility of quantitative measurement of T2 using restriction spectrum imaging for detection of clinically significant prostate cancer.

Journal: Scientific reports
Published: June 05, 2024

Quantitative MRI biomarker for classification of clinically significant prostate cancer: Calibration for reproducibility across echo times.

Quantitative MRI biomarker for classification of clinically significant prostate cancer: Calibration for reproducibility across echo times.

Journal: Journal of applied clinical medical physics
Published: February 12, 2024

Quantitative MRI biomarker for classification of clinically significant prostate cancer: calibration for reproducibility across echo times.

Quantitative MRI biomarker for classification of clinically significant prostate cancer: calibration for reproducibility across echo times.

Journal: medRxiv : the preprint server for health sciences
Published: February 12, 2024

Clinical Impact of Contouring Variability for Prostate Cancer Tumor Boost.

Clinical Impact of Contouring Variability for Prostate Cancer Tumor Boost.

Journal: International journal of radiation oncology, biology, physics
Published: January 31, 2024

Comparison of synthesized and acquired high b-value diffusion-weighted MRI for detection of prostate cancer.

Comparison of synthesized and acquired high b-value diffusion-weighted MRI for detection of prostate cancer.

Journal: Cancer imaging : the official publication of the International Cancer Imaging Society
Published: December 19, 2023
Showing 1-12 of 29

Last Updated: 09/26/2026